Latest filing published 31 Jan 2024 for Cyclacel Pharmaceuticals, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Brian Schwartz, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Bio Green Med Solution, Inc., Arqule Inc and Infinity Pharmaceuticals, Inc. The record holds 6 filings, for trades running from 14 January 2016 to 29 January 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 31 January 2024, the filings show a share grant in Bio Green Med Solution, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations